AI Chat Paper
Discover the SciOpen Platform and Achieve Your Research Goals with Ease.
Loss of susceptibility to anoikis signals is a crucial step in metastasis. Anoikis resistance therefore represents a promising adjuvant therapeutic target for cancer management. In this study, we have conducted a rationalized screening to search for novel leading anoikis sensitizer from daily foods. Among 19 tested dietary phytochemicals, the best results were obtained with apigenin, a natural component of celery. Phenotypically, apigenin sensitized breast cancer cells to anoikis, lowered the number of circulating tumor cells, and protected against breast cancer metastasis to lung in mice. Mechanistically, we demonstrated that the thromboxane A2 (TXA2)-TXA2 receptor (TP) axis has a critical role in acquired anoikis resistance by activating PI3K-Akt signaling pathway. Blockage of TXA2 signaling up-regulated p53 as well as its target gene p21, caused a G1 phase arrest, and finally led to apoptosis in breast cancer cells. TXA2 level was positively correlated with breast cancer cell anoikis rate, and apigenin significantly inhibited TXA2 biosynthesis in vitro and in vivo. Collectively, we identified apigenin as a potent anoikis sensitizer with anti-metastatic properties in a mouse model of breast cancer, and these findings might provide a rationale for introducing apigenin supplementation to breast cancer patients.
C. Xia, X. Dong, H. Li, et al., Cancer statistics in China and United States, 2022: profiles, trends, and determinants, Chin. Med. J. 135(5) (2022) 584-590. https://doi.org/10.1097/CM9.0000000000002108.
P.S. Steeg, Targeting metastasis, Nat. Rev. Cancer 16 (2006) 201-218. https://doi.org/10.1038/nrc.2016.25.
P. Mehlen, A. Puisieux, Metastasis: a question of life or death, Nat. Rev. Cancer 6(6) (2006) 449-458. https://doi.org/10.1038/nrc1886.
B. Weigelt, J.L. Peterse, L.J. van’t Veer, Breast cancer metastasis: markers and models, Nat. Rev. Cancer 5(8) (2005) 591-602. https://doi.org/10.1038/nrc1670.
C.L. Buchheit, K.J. Weigel, Z.T. Schafer, Cancer cell survival during detachment from the ECM: multiple barriers to tumour progression, Nat Rev Cancer 14(9) (2014) 632-641. https://doi.org/10.1038/nrc3789.
Y.N. Kim, K.H. Koo, J.Y. Sung, et al., Anoikis resistance: an essential prerequisite for tumor metastasis, Int. J. Cell Bio. 2012(4) (2012) 306879. https://doi.org/10.1155/2012/306879.
H.F. Zhang, C.S. Hughes, W. Li, et al., Proteomic screens for suppressors of anoikis identify IL1RAP as a promising surface target in ewing sarcoma, Cancer Discov. 11(11) (2021) 2884-2903. https://doi.org/10.1158/2159-8290.CD-20-1690.
J. Massague, A.C. Obenauf, Metastatic colonization by circulating tumour cells, Nature 529(7586) (2016) 298-306. https://doi.org/10.1038/nature17038.
A.J. Minn, G.P. Gupta, P.M. Siegel, et al., Genes that mediate breast cancer metastasis to lung, Nature 436(7050) (2005) 518-524. https://doi.org/10.1038/nature17038.
C.R. Bohl, S. Harihar, W.L. Denning, et al., Metastasis suppressors in breast cancers: mechanistic insights and clinical potential, J. Mol. Med. 92(1) (2014) 13-30. https://doi.org/10.1007/s00109-013-1109-y.
J. Song, Y. Liu, F. Liu, et al., The 14-3-3σ protein promotes HCC anoikis resistance by inhibiting EGFR degradation and thereby activating the EGFR-dependent ERK1/2 signaling pathway, Theranostics 11(3) (2021) 996-1015. https://doi.org/10.7150/thno.51646.
L. Vitillo, M. Baxter, B. Iskender, et al., Integrin-associated focal adhesion kinase protects human embryonic stem cells from apoptosis, detachment, and differentiation, Stem Cell Rep. 7(2) (2016) 167-176. https://doi.org/10.1016/j.stemcr.2016.07.006.
J.L. Fritz, O. Collins, P. Saxena, et al., A novel role for NUAK1 in promoting ovarian cancer metastasis through regulation of fibronectin production in spheroids, Cancers 12(5) (2020) 1250. https://doi.org/10.3390/cancers12051250.
H. Cheng, P. Liu, Z.C. Wang, et al., SIK1 Couples LKB1 to p53-dependent anoikis and suppresses metastasis, Sci. Signal. 2(80) (2009) ra35. https://doi.org/10.1126/scisignal.2000369.
L. Jin, J. Chun, C. Pan, et al., The PLAG1-GDH1 axis promotes anoikis resistance and tumor metastasis through CamKK2-AMPK signaling in LKB1-deficient lung cancer, Mol Cell 69(1) (2018) 87-99 e7. https://doi.org/10.1016/j.molcel.2017.11.025.
S. Chikara, L.D. Nagaprashantha, J. Singhal, et al., Oxidative stress and dietary phytochemicals: role in cancer chemoprevention and treatment, Cancer Lett. 413 (2018) 122-134. https://doi.org/10.1016/j.canlet.2017.11.002
F. Zhang, W. Dong, W. Zeng, et al., Naringenin prevents TGF-beta1 secretion from breast cancer and suppresses pulmonary metastasis by inhibiting PKC activation, Breast Cancer Res. 18(1) (2016) 38. https://doi.org/10.1186/s13058-016-0698-0.
H.E. Elsayed, H.Y. Ebrahim, M.M. Mohyeldin, et al., Rutin as a novel c-met inhibitory lead for the control of triple negative breast malignancies, Nut. Cancer 69(8) (2017) 1-16. https://doi.org/10.1080/01635581.2017.1367936.
M.S. G, M. Swetha, C.K. Keerthana, et al., Cancer chemoprevention: a strategic approach using phytochemicals, Front. Pharmacol. 12 (2021) 809308. https://doi.org/10.3389/fphar.2021.809308.
H.A. Saleh, M.H. Yousef, A. Abdelnaser, The anti-inflammatory properties of phytochemicals and their effects on epigenetic mechanisms involved in TLR4/NF-κB-mediated inflammation, Front. Immunol. 12 (2021) 606069. https://doi.org/10.3389/fimmu.2021.606069.
B.A. Pulaski, S. Ostrand-Rosenberg, Mouse 4T1 breast tumor model, current protocols in immunology 39 (2001) Chapter 20:Unit 20.2. https://doi.org/10.1002/0471142735.im2002s39.
J. Yang, S.A. Mani, J.L. Donaher, et al., Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis, Cell 117(7) (2004) 927-939. https://doi.org/10.1016/j.cell.2004.06.006.
S.M. Ding, Z.H. Zhang, J. Song, et al., Enhanced bioavailability of apigenin via preparation of a carbon nanopowder solid dispersion, Int. J. Nanomed. 9 (2014) 2327-2333. https://doi.org/10.2147/IJN.S60938.
S. Lucotti, C. Cerutti, M. Soyer, et al., Aspirin blocks formation of metastatic intravascular niches by inhibiting platelet-derived COX-1/thromboxane A2, J. Clin. Invest. 129(5) (2019) 1845-1862. https://doi.org/10.1172/JCI121985.
M. Lelekakis, J.M. Moseley, T.J. Martin, et al., A novel orthotopic model of breast cancer metastasis to bone, Clin. Exp. Metastas. 17(2) (1999) 163-170. https://doi.org/10.1023/a:1006689719505.
R. Xu, Y. Yan, X. Zheng, et al., Aspirin suppresses breast cancer metastasis to lung by targeting anoikis resistance, Carcinogenesis 43 (2022) 104-114. https://doi.org/10.1093/carcin/bgab117.
L. Chibaya, B. Karim, H. Zhang, S.N. Jones, Mdm2 phosphorylation by Akt regulates the p53 response to oxidative stress to promote cell proliferation and tumorigenesis, Proc. Nat. Acad. Sci. 118(4) (2021) e2003193118. https://doi.org/10.1073/pnas.2003193118.
N. Nakahata, Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology, Pharmacol. Therapeut. 118(1) (2008) 18-35. https://doi.org/10.1016/j.pharmthera.2008.01.001.
E. Shankar, A. Goel, K. Gupta, S. Gupta, Plant flavone apigenin: an emerging anticancer agent, Curr. Pharma. Rep. 3(6) (2017) 1-24. https://doi.org/10.1007/s40495-017-0113-2.
X. Feng, D. Weng, F. Zhou, et al., Activation of PPARγ by a natural flavonoid modulator, apigenin ameliorates obesity-related inflammation via regulation of macrophage polarization, EBioMedicine 9 (2016) 61-76. https://doi.org/10.1016/j.ebiom.2016.06.017.
K. Yamagata, C. Tagawa, H. Matsufuji, M. Chino, Dietary apigenin regulates high glucose and hypoxic reoxygenation-induced reductions in apelin expression in human endothelial cells, J. Nutr. Biochem. 23(8) (2012) 929-936. https://doi.org/10.1016/j.jnutbio.2011.04.019.
C. Yang, J. Song, S. Hwang, et al., Apigenin enhances apoptosis induction by 5-fluorouracil through regulation of thymidylate synthase in colorectal cancer cells, Redox Biology 47 (2021) 102144. https://doi.org/10.1016/j.redox.2021.102144.
Y.W. Li, J. Xu, G.Y. Zhu, et al., Apigenin suppresses the stem cell-like properties of triple-negative breast cancer cells by inhibiting YAP/TAZ activity, Cell Death Discov. 4 (2018) 105. https://doi.org/10.1038/s41420-018-0124-8.
M.R.P. Coombs, M.E. Harrison, D.W. Hoskin, Apigenin inhibits the inducible expression of programmed death ligand 1 by human and mouse mammary carcinoma cells, Cancer Lett. 380(2) (2016) 424-433. https://doi.org/10.1016/j.canlet.2016.06.023.
M.A. Hasnat, M. Pervin, J.H. Lim, et al. Apigenin attenuates melanoma cell migration by inducing anoikis through integrin and focal adhesion kinase inhibition, Molecules 20(12) (2015) 21157-21166. https://doi.org/10.3390/molecules201219752.
L. Jiang, Y. Luan, X. Miao, et al., Platelet releasate promotes breast cancer growth and angiogenesis via VEGF-integrin cooperative signalling, Br. J. Cancer 117(5) (2017) 695-703. https://doi.org/10.1038/bjc.2017.214.
B. Strilic, S. Offermanns, Intravascular survival and extravasation of tumor cells, Cancer Cell 32(3) (2017) 282-293. https://doi.org/10.1016/j.ccell.2017.07.001.
D.L. Tao, S. Tassi Yunga, C.D. Williams, et al., Aspirin and antiplatelet treatments in cancer, Blood 137(23) (2021) 3201-3211. https://doi.org/10.1182/blood.2019003977.
Navarro-Núñez L, Castillo J, Lozano ML, et al., Thromboxane A2 receptor antagonism by flavonoids structure-activity relationships, J. Agric. Food Chem. 57(4) (2009) 1589-1594. https://doi.org/10.1021/jf803041k.
S. Del Turco, S. Sartini, G. Cigni, et al., Synthetic analogues of flavonoids with improved activity against platelet activation and aggregation as novel prototypes of food supplements, Food Chem. 175 (2015) 494-499. https://doi.org/10.1016/j.foodchem.2014.12.005.
B.K. Kim, A.R. Cho, D.J. Park, Enhancing oral bioavailability using preparations of apigenin-loaded W/O/W emulsions: in vitro and in vivo evaluations, Food Chem. 206 (2016) 85-91. https://doi.org/10.1016/j.foodchem.2016.03.052.
665
Views
88
Downloads
0
Crossref
0
Web of Science
0
Scopus
0
CSCD
Altmetrics
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
